Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Deciphera Pharmaceuticals revenue
Deciphera Pharmaceuticals's revenue is $163.4 million.
What is Deciphera Pharmaceuticals's revenue?
- Deciphera Pharmaceuticals's revenue growth from 2019 to 2023 is 553.42%.
- Deciphera Pharmaceuticals has 200 employees, and the revenue per employee ratio is $816,780.
- Deciphera Pharmaceuticals's peak quarterly revenue was $48.3M in 2023(q4).
- Deciphera Pharmaceuticals peak revenue was $163.4M in 2023.
- Deciphera Pharmaceuticals annual revenue for 2022 was 134.0M, 39.41% growth from 2021.
- Deciphera Pharmaceuticals annual revenue for 2023 was 163.4M, 21.87% growth from 2022.
On this page
Zippi applies for you, and finds you a job.
Deciphera Pharmaceuticals historical revenue
Deciphera Pharmaceuticals's peak revenue was $163.4M in 2023. The peak quarterly revenue was $48.3M in 2023(q4).
Deciphera Pharmaceuticals's revenue increased from $25.0m in 2019 to $163.4M currently. That's a 553.42% change in annual revenue.
Deciphera Pharmaceuticals annual revenue
Deciphera Pharmaceuticals annual revenue over time
| Fiscal year / year | Deciphera Pharmaceuticals revenue |
|---|---|
| 2019 | $25.0M |
| 2020 | $42.1M |
| 2021 | $96.1M |
| 2022 | $134.0M |
| 2023 | $163.4M |
How accurately did Deciphera Pharmaceuticals' revenue projections match actual performance?
Deciphera Pharmaceuticals annual growth
Deciphera Pharmaceuticals saw the greatest revenue growth in 2021, when revenue increased by 128.45%.
Deciphera Pharmaceuticals had the lowest revenue growth in 2022, when revenue changed by 39.41%.
Deciphera Pharmaceuticals annual growth rate over time
| Year | Deciphera Pharmaceuticals growth |
|---|---|
| 2020 | 68%↑ |
| 2021 | 128%↑ |
| 2022 | 39%↑ |
| 2023 | 22%↑ |
Deciphera Pharmaceuticals quarterly revenue over time
- Q1
- Q2
- Q3
- Q4
Deciphera Pharmaceuticals quarterly growth rate over time
| Year | Q1 | Q2 | Q3 | Q4 |
|---|---|---|---|---|
| 2019 | - | $25.0M | - | - |
| 2020 | $62,000 | $7.1M | $15.4M | $19.5M |
| 2021 | $25.2M | $23.6M | $23.2M | $24.2M |
| 2022 | $29.2M | $32.5M | $36.0M | $36.3M |
| 2023 | $33.4M | $38.3M | $43.3M | $48.3M |
| 2024 | $45.0M | - | - | - |
Deciphera Pharmaceuticals jobs nearby
Do you work at Deciphera Pharmaceuticals?
Did Deciphera Pharmaceuticals meet its revenue projections?
Deciphera Pharmaceuticals financial information
| CEO | Steven L. Hoerter |
| Company Type | Public |
| Employees Number | 200 |
| Date Founded | 2003 |
| Headquarters | Waltham, Massachusetts |
| Number of Locations | 2 |
| Revenue | $163.4M |
| Net Income | -$178,931,000 |
| Gross Proft | $159.6M (2023) |
| Tax Rate | -0.0% |
| Total Assets | $454,039,000 |
| Ticker | DCPH |
Deciphera Pharmaceuticals jobs you might like
Deciphera Pharmaceuticals financing
Deciphera Pharmaceuticals received early financing of $75.0M on 2015-09-21.
| Series | Round size | Date |
|---|---|---|
| Series B | $75M | 09/2015 |
| Series B | $15M | 01/2016 |
| Series C | $52M | 06/2017 |
| Post Ipo Equity | $172M | 06/2018 |
| Post Ipo Equity | $400M | 08/2019 |
Deciphera Pharmaceuticals investors
| Investors | Security type |
|---|---|
| New Leaf Venture Partners | Series B |
| SV Health Investors LLC | Series B |
| Viking Global Investors | Series C |
| Redmile Group | Series C |
| Sphera Global Healthcare Fund | Series C |
| New Leaf Venture Partners | Series C |
Deciphera Pharmaceuticals competitors
Deciphera Pharmaceuticals's top competitor, PTC Therapeutics, earned an annual revenue of $806.8M.
Deciphera Pharmaceuticals's smallest competitor is Onconova Therapeutics with revenue of $226.0K last year.
| Company name | Average salary | Revenue | Employee size | Job openings |
|---|---|---|---|---|
| Epizyme | $86,952 | $37.4M | 124 | - |
| Onyx Pharmaceuticals | $95,378 | $362.2M | 500 | - |
| Kura Oncology | $74,823 | $53.9M | 121 | 7 |
| Genprex | $47,428 | $45.0M | 7 | - |
| Verastem Oncology | $101,471 | $10.0M | 150 | 7 |
| PTC Therapeutics | $92,986 | $806.8M | 517 | 20 |
| Onconova Therapeutics | $51,735 | $226,000 | 12 | - |
| ORIC Pharmaceuticals | $68,754 | $450.9M | 61 | 9 |
| Tetralogic Pharmaceuticals | $52,034 | - | 20 | - |
| Scholar Rock | $82,975 | $33.2M | 119 | 32 |
Deciphera Pharmaceuticals revenue FAQs
Search for jobs
Related company revenues
Working at related companies
Related company jobs
Deciphera Pharmaceuticals highest paying jobs
Zippia gives an in-depth look into the details of Deciphera Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Deciphera Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Deciphera Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Deciphera Pharmaceuticals. The data presented on this page does not represent the view of Deciphera Pharmaceuticals and its employees or that of Zippia.
Deciphera Pharmaceuticals may also be known as or be related to DECIPHERA PHARMACEUTICALS, INC., Deciphera Pharmaceuticals, Deciphera Pharmaceuticals LLC, Deciphera Pharmaceuticals, Inc. and Deciphera Pharmaceuticals, LLC.